Vivelle-Dot estradiol transdermal system

Vivelle-Dot is a transdermal patch containing estradiol, an estrogen hormone used in hormone replacement therapy (HRT) for postmenopausal women. It is manufactured by Novartis Pharmaceuticals Corporation, a global healthcare company headquartered in Switzerland. The product is produced in multiple countries, including the United States, Canada, and New Zealand. In the United States, Vivelle-Dot is marketed under the National Drug Code (NDC) 0078-0365. (fda.report) The brand is owned by Novartis Pharmaceuticals Corporation, which is based in Switzerland. There are no known subsidiaries that own the brand locally.